BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bloom DC, Tran RK, Feller J, Voellmy R. Immunization by Replication-Competent Controlled Herpesvirus Vectors. J Virol 2018;92:e00616-18. [PMID: 29899091 DOI: 10.1128/JVI.00616-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Uche IK, Fowlkes N, Vu L, Watanabe T, Carossino M, Nabi R, Del Piero F, Rudd JS, Kousoulas KG, Rider PJF. Novel Oncolytic Herpes Simplex Virus 1 VC2 Promotes Long-Lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-Derived Mouse Melanoma Model. J Virol 2021;95:e01359-20. [PMID: 33177208 DOI: 10.1128/JVI.01359-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Bloom DC, Tran RK, Feller J, Voellmy R. Immunization by Replication-Competent Controlled Herpesvirus Vectors. J Virol 2018;92:e00616-18. [PMID: 29899091 DOI: 10.1128/JVI.00616-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Voellmy R, Bloom DC, Vilaboa N. Herpes Simplex Viruses Whose Replication Can Be Deliberately Controlled as Candidate Vaccines. Vaccines (Basel) 2020;8:E230. [PMID: 32443425 DOI: 10.3390/vaccines8020230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Stanfield BA, Kousoulas KG, Fernandez A, Gershburg E. Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses. Viruses 2021;13:1637. [PMID: 34452501 DOI: 10.3390/v13081637] [Reference Citation Analysis]